Discover comprehensive ADHD treatment options in the UK: medication guidelines (methylphenidate, lisdexamfetamine), NICE recommendations, NHS vs private care, therapy options, titration process, and support resources for adults and children.

Discover the complete UK ADHD titration protocol: timeline, dosing guidelines for methylphenidate & lisdexamfetamine, monitoring requirements, side effects, FAQs, and what happens after titration ends. Essential for adults starting ADHD medication.

Complete guide to NICE NG87 ADHD medication guidelines: first-line stimulants, dosing (methylphenidate 18-108mg, lisdexamfetamine 30-70mg), monitoring requirements, shared care agreements, and what every UK adult needs to know.

Discover what an independent ADHD nurse prescriber is, how nurse-led ADHD care works in the UK, qualifications, costs, benefits vs psychiatrists, and how to access this growing treatment option.

Everything you need to know about private ADHD prescribing in the UK: costs £50-160/month, assessment £500-1200, shared care agreements, GP acceptance, and how to choose the right clinic.

Discover everything UK adults need to know about ADHD medication in 2026: NHS vs private treatment, stimulant & non-stimulant options, costs, side effects, and how to start treatment.

Discover how nurse prescribers in the UK can diagnose ADHD and prescribe medication. Learn about qualifications, costs, wait times, and why nurse-led ADHD care is growing.

Need an ADHD medication review template for primary care? Get a comprehensive GP checklist, monitoring requirements, NICE guidelines compliance, and FAQs for safe ADHD reviews.

Understanding the Weiss Functional Impairment Scale (WFIRS) for ADHD? Learn what it measures, how scoring works, why it matters for treatment, and answers to common patient FAQs.

Understanding ADHD annual reviews under NICE NG87 guidelines? Learn what's included, how often reviews are needed, monitoring requirements, and answers to common patient FAQs.

Understanding ADHD shared care protocols with nurse prescribers? Learn what they are, how they work, your rights, monitoring requirements, and answers to common patient FAQs.

Learn about atomoxetine (Strattera) and QT prolongation risks, cardiac side effects, monitoring recommendations, and who should avoid this ADHD medication. Expert-backed FAQs included.

Learn what atomoxetine QT prolongation means, who may be at risk, how to monitor heart safety, and when to seek medical advice.

Compare methylphenidate vs lisdexamfetamine for adults with ADHD, including effectiveness, side effects, duration, FAQs, and key decision factors.

Learn what to ask, track, and prepare before starting ADHD medication with this practical initiation checklist, FAQs, and safety tips.

Learn the key Elvanse prescribing guidelines for adults in the UK, including assessment, monitoring, contraindications, titration, shared care and FAQs.

Learn the main lisdexamfetamine contraindications in the UK, including cardiovascular, psychiatric and medication risks, plus FAQs and safety guidance.

Discover how the Weiss ADHD review tool supports adult ADHD assessment, symptom review, impairment tracking and safer treatment decisions in clinical practice.

Explore ADHD clinical decision support in the UK, including NICE-aligned assessment, prescribing, monitoring, and safer ADHD care pathways for clinicians and patients.

Use this methylphenidate contraindications checker guide to identify who should not take methylphenidate, key red flags, safety checks, and prescriber considerations.